QQ客服 官方微博 反馈留言

	Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects
	Yang, H.; Feng, Y.; Cai, H.; Jia, D.; Li, H.; Tao, Z.; Zhong, Y.; Li, Z.; Shi, Q.; Wan, L.
刊名	Theranostics
	2018
卷号	Vol.8 No.9页码:2459-2476
关键词	Affinity-controlled release Albumin Biopharmaceuticals Drug delivery Immunoglobulin
ISSN号	1838-7640
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1821411
专题	四川大学
作者单位	1.Proteomics and Metabolomics Laboratory, West China-Washington Mitochondria and Metabolism Research Center, West China Hospital, Sichuan University, Chengdu, China 2.Department of Nuclear Medicine, Sichuan University, Chengdu, China 3.a Key Lab of Transplant Engineering and Immunology, MOH, Sichuan University, Chengdu, China 4.College of Pharmacy, Liaocheng University, Liaocheng, Shandong, China
推荐引用方式 GB/T 7714	Yang, H.,Feng, Y.,Cai, H.,et al. Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects[J]. Theranostics,2018,Vol.8 No.9:2459-2476.
APA	Yang, H..,Feng, Y..,Cai, H..,Jia, D..,Li, H..,...&Lu, X..(2018).Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects.Theranostics,Vol.8 No.9,2459-2476.
MLA	Yang, H.,et al."Endogenous IgG-based affinity-controlled release of TRAIL exerts superior antitumor effects".Theranostics Vol.8 No.9(2018):2459-2476.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。